Pitt Shield

Enhancement of cerebrospinal fluid tracer movement by the application of pulsed transcranial focused ultrasound.

Authors: Yoo SS, Kim HC, Kim J, Kim E, Kowsari K, Van Reet J, Yoon K

Efficient transport of solutes in the cerebrospinal fluid (CSF) plays a critical role in their clearance from the brain. Convective bulk flow of solutes in the CSF in the perivascular space (PVS) is considered one of the important mechanisms behind solute movement in the brain, before their ultimate drainage to the systemic lymphatic system. Acoustic pressure waves can impose radiation force on a medium in its path, inducing localized and directional fluidic flow, known as acoustic streaming. We transcranially applied low-intensity focused ultrasound (FUS) to rats that received an intracisternal injection of fluorescent CSF tracers (dextran and ovalbumin, having two different molecular weights-M<sub>w</sub>). The sonication pulsing parameter was determined on the set that propelled the aqueous solution of toluidine blue O dye into a porous media (melamine foam) at the highest level of infiltration. Fluorescence imaging of the brain showed that application of FUS increased the uptake of ovalbumin at the sonicated plane, particularly around the ventricles, whereas the uptake of high-M<sub>w</sub> dextran was unaffected. Numerical simulation showed that the effects of sonication were non-thermal. Sonication did not alter the animals' behavior or disrupt the blood-brain barrier (BBB) while yielding normal brain histology. The results suggest that FUS may serve as a new non-invasive means to promote interstitial CSF solute transport in a region-specific manner without disrupting the BBB, providing potential for enhanced clearance of waste products from the brain.

Introduction

Purpose Other
Study Objective To determine if transcranial FUS can enhance cerebrospinal fluid tracer movement into the brain and increase transport following intracisternal injection
Animal model / Human subject Rattus norvegicus (rat), Sprague–Dawley (SD); age: not specified/not reported; sex: male
Disease model healthy
MRI or image guidance method Not specified
Targeted brain region(s) Periventricular region
Target coordinates 2 mm caudal to the bregma in 1 mm depth from the top of the head
Cargo name and characteristics Texas Red–labeled Ovalbumin (45 kDa), FITC-dextran (2000 kDa)
Route of administration Intracisternal injection into the cisterna magna (CSF tracers: Texas Red ovalbumin and FITC-dextran); intravenous (tail‑vein) injection for trypan blue BBB assessment.

Outcomes and Safety

Summary of Outcomes FUS increased brain uptake of the 45 kDa Texas Red-ovalbumin tracer, while FITC-dextran 2000 kDa was minimal and unchanged. Enhanced tracer movement occured at the sonicated plane for both ventral and dorsal sonication approaches
Duration of biological effect Not reported
Safety-related matter The study reports no adverse effects: low‑intensity pulsed FUS produced negligible heating (<0.03°C), did not alter animal behavior, disrupt the blood–brain barrier, or cause histological tissue damage, though cavitation is noted as a theoretical risk at higher pressures.

Brain Region

Ultrasound Parameters

Ultrasound instrument GS200-D25-P38 (FUS transducer), Ultran Group, State College, PA; transducer diameter 28 mm, curvature radius 22 mm
FUS Frequency 200 kHz
FUS Intensity I_SPPA = 5 W/cm2; duty cycle 10% (100 ms PD, 1 Hz PRF) → I_SPTA = 0.5 W/cm2
FUS Pressure ≈0.38 MPa (estimated peak pressure corresponding to ISPPA = 5 W/cm^2)
FUS Mode pulsed
Pulse duration 100 ms
Duration of a single FUS session 30 minutes
Focal Characteristics focal distance: 11 mm, focal diameter: 5 mm, focal length : 15 mm and 27 mm, focal diameter: 7 mm
Treatment frequency single session

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search